Top Markets
Coin of the day
Harrow Health, Inc. 8.625% Senior Notes due 2026 Harrow Health, Inc. 8.625% Senior Notes due 2026

Harrow Health, Inc. 8.625% Senior Notes due 2026

HROWL
Rangering i aksjer #8091
Harrow, Inc. is a pharmaceutical company that specializes in the development,... Harrow, Inc. is a pharmaceutical company that specializes in the development, production, and distribution of innovative medications. Its business activities are primarily divided into two segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding division notably encompasses the operations of the ImprimisRx business. Co-founded by Mark L. Baum and Robert J. Kammer in January 2006, the firm maintains its corporate headquarters in Nashville, Tennessee.
Aksjekurs
$25.61
Sist synkronisert: 2025-10-10
Markedsverdi
$1.37B
Endring (1 dag)
0.20%
Endring (1 år)
1.59%
Land
US
Handel Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL)

Kategori

Utbyttehistorikk for Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL)
Harrow Health, Inc. 8.625% Senior Notes due 2026 (aksjesymbol: HROWL) har gitt totalt 0 utbyttebetalinger.
Summen av alle utbytter (justert for aksjesplitt): 0.00
Utbytteavkastning (TTM): 0
Utbyttebetalinger for Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL) fra 2026 til 2026
Årlige utbyttebetalinger
År Utbytte (justert for aksjesplitt) Endre
Ikke nok data for de angitte datoene.
Liste over alle utbyttebetalinger
År Utbytte Endre
Ikke nok data for de angitte datoene.
Utbyttebetalinger for lignende selskaper eller konkurrenter